UPDATED Aug 17, 2025
Discover small cap Global Pharmaceuticals & Biotech companies from around the world. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
2268 | HK$61.55 | 5.4% | 225.3% | HK$74.1b | HK$56.67 | PE63.6x | E24.8% | n/a | ||
BBIO | US$51.32 | 6.4% | 103.9% | US$9.8b | US$62.43 | PS41.6x | E69.3% | n/a | ||
600196 | CN¥28.53 | 6.5% | 22.5% | CN¥70.6b | CN¥29.24 | PE25.8x | E10.0% | 1.1% | ||
603392 | CN¥55.96 | -1.1% | -19.1% | CN¥70.8b | CN¥53.10 | PS37.4x | E105.8% | 0% | ||
SOBI | SEK 273.80 | 0.3% | -12.2% | SEK 94.4b | SEK 344.50 | PE21.6x | E16.0% | n/a | ||
300765 | CN¥51.21 | 1.6% | 118.9% | CN¥71.3b | CN¥54.60 | PS34.6x | E65.1% | 0.04% | ||
1530 | HK$32.52 | 6.7% | 399.5% | HK$77.8b | HK$31.09 | PE34.2x | E0.2% | 0.8% | ||
CAI | US$36.50 | 20.8% | n/a | US$10.3b | US$39.38 | PS19.2x | E80.2% | n/a | ||
500257 | ₹1,969.45 | 1.2% | -4.8% | ₹899.5b | ₹2,229.14 | PE24.3x | E4.6% | 0.6% | ||
EXEL | US$38.31 | 2.4% | 44.1% | US$10.3b | US$44.74 | PE17.1x | E19.9% | n/a | ||
RVTY | US$90.78 | 5.8% | -24.5% | US$10.5b | US$116.81 | PE37.8x | E24.3% | 0.3% | ||
QGEN | US$49.35 | 2.8% | 2.2% | US$10.7b | US$52.39 | PE28.7x | E11.9% | 3.1% | ||
IPN | €113.90 | 7.8% | 6.7% | €9.3b | €127.00 | PE21x | E11.5% | 1.2% | ||
MRNA | US$28.02 | 10.0% | -68.9% | US$10.9b | US$45.60 | PS3.5x | E37.1% | n/a | ||
BMRN | US$57.54 | 1.3% | -38.0% | US$11.0b | US$97.62 | PE16.8x | E17.2% | n/a | ||
ORNBV | €67.80 | 2.2% | 45.4% | €9.5b | €66.75 | PE25.2x | E13.8% | 2.4% | ||
ZYDUSLIFE | ₹986.50 | 3.2% | -16.7% | ₹992.6b | ₹1,002.83 | PE21.7x | E-2.5% | 1.1% | ||
MANKIND | ₹2,472.40 | 1.4% | 6.6% | ₹1.0t | ₹2,799.65 | PE53.9x | E20.4% | 0.08% | ||
ASND | US$198.32 | 1.2% | 43.9% | US$12.0b | US$252.08 | PS20.9x | E60.4% | n/a | ||
500124 | ₹1,263.85 | 3.7% | -8.6% | ₹1.1t | ₹1,285.63 | PE18.5x | E-1.2% | 0.6% | ||
REC | €51.75 | 2.3% | 2.7% | €10.6b | €59.62 | PE26.2x | E14.1% | 2.5% | ||
VTRS | US$10.61 | 7.6% | -10.3% | US$12.4b | US$11.43 | PB0.8x | E77.9% | 4.5% | ||
TEM | US$73.78 | 21.3% | 28.1% | US$12.8b | US$70.00 | PS13.5x | E12.3% | n/a | ||
MEDP | US$457.85 | 1.8% | 16.8% | US$12.9b | US$410.27 | PE30.7x | E8.6% | n/a |